Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 18445664)

1.

Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.

Utz AL, Yamamoto A, Hemphill L, Miller KK.

J Clin Endocrinol Metab. 2008 Jul;93(7):2507-14. doi: 10.1210/jc.2008-0169. Epub 2008 Apr 29.

2.

Relative growth hormone deficiency and cortisol excess are associated with increased cardiovascular risk markers in obese adolescent girls.

Russell M, Bredella M, Tsai P, Mendes N, Miller KK, Klibanski A, Misra M.

J Clin Endocrinol Metab. 2009 Aug;94(8):2864-71. doi: 10.1210/jc.2009-0380. Epub 2009 May 12.

3.

The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.

Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G.

Eur J Endocrinol. 2005 Aug;153(2):257-64.

4.

The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.

Colao A, Di Somma C, Spiezia S, Rota F, Pivonello R, Savastano S, Lombardi G.

J Clin Endocrinol Metab. 2006 Jun;91(6):2191-200. Epub 2006 Mar 14.

PMID:
16537686
5.

Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity.

Makimura H, Stanley T, Mun D, Chen C, Wei J, Connelly JM, Hemphill LC, Grinspoon SK.

J Clin Endocrinol Metab. 2009 Dec;94(12):5131-8. doi: 10.1210/jc.2009-1295. Epub 2009 Oct 16.

6.

GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.

Carmichael JD, Danoff A, Milani D, Roubenoff R, Lesser ML, Livote E, Reitz RE, Ferris S, Kleinberg DL.

Clin Endocrinol (Oxf). 2006 Aug;65(2):169-77.

7.

Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.

Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R.

J Clin Endocrinol Metab. 2001 Mar;86(3):1061-5.

PMID:
11238486
8.

The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis.

Scacchi M, Orsini F, Cattaneo A, Grasso A, Filippini B, Pecori Giraldi F, Fatti LM, Moro M, Cavagnini F.

Eur J Endocrinol. 2010 Aug;163(2):201-6. doi: 10.1530/EJE-10-0160. Epub 2010 May 11.

9.

Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly.

Lin E, Wexler TL, Nachtigall L, Tritos N, Swearingen B, Hemphill L, Loeffler J, Biller BM, Klibanski A, Miller KK.

Clin Endocrinol (Oxf). 2012 Sep;77(3):430-8. doi: 10.1111/j.1365-2265.2012.04361.x.

10.

Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.

Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E, Benso L, Camanni F, Ghigo E.

J Clin Endocrinol Metab. 2000 Oct;85(10):3693-9.

PMID:
11061526
12.

The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.

Colao A, Cerbone G, Pivonello R, Aimaretti G, Loche S, Di Somma C, Faggiano A, Corneli G, Ghigo E, Lombardi G.

J Clin Endocrinol Metab. 1999 Apr;84(4):1277-82.

PMID:
10199767
13.

Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.

Link K, Moëll C, Garwicz S, Cavallin-Ståhl E, Björk J, Thilén U, Ahrén B, Erfurth EM.

J Clin Endocrinol Metab. 2004 Oct;89(10):5003-12.

PMID:
15472198
14.

Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.

Utz AL, Yamamoto A, Sluss P, Breu J, Miller KK.

J Clin Endocrinol Metab. 2008 Oct;93(10):4033-40. doi: 10.1210/jc.2008-0930. Epub 2008 Jul 22.

15.

Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.

Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E.

J Clin Endocrinol Metab. 2001 Apr;86(4):1574-9.

PMID:
11297586
16.

The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors.

Cordido F, Garcia-Buela J, Sangiao-Alvarellos S, Martinez T, Vidal O.

Mediators Inflamm. 2010;2010:434562. doi: 10.1155/2010/434562. Epub 2010 Jan 21.

17.

The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men.

Makimura H, Stanley T, Mun D, You SM, Grinspoon S.

J Clin Endocrinol Metab. 2008 Nov;93(11):4254-60. doi: 10.1210/jc.2008-1333. Epub 2008 Sep 2.

18.

Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults.

Corneli G, Di Somma C, Prodam F, Bellone J, Bellone S, Gasco V, Baldelli R, Rovere S, Schneider HJ, Gargantini L, Gastaldi R, Ghizzoni L, Valle D, Salerno M, Colao A, Bona G, Ghigo E, Maghnie M, Aimaretti G.

Eur J Endocrinol. 2007 Dec;157(6):701-8.

19.
20.

Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.

Miller KK, Wexler T, Fazeli P, Gunnell L, Graham GJ, Beauregard C, Hemphill L, Nachtigall L, Loeffler J, Swearingen B, Biller BM, Klibanski A.

J Clin Endocrinol Metab. 2010 Feb;95(2):567-77. doi: 10.1210/jc.2009-1611. Epub 2010 Jan 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk